IONS

Ionis Pharmaceuticals, Inc.

40.59 USD
-0.06 (-0.15%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Ionis Pharmaceuticals, Inc. stock is up 8.79% since 30 days ago. The next earnings date is Aug 7, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 77.78% of the previous 8 June’s closed higher than May. In the last 10 Unusual Options Trades, there were 9 CALLs, 1 PUT. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
03 Jun 15:55 16 Aug, 2024 35.00 CALL 50 1
04 Jun 14:56 20 Sep, 2024 40.00 CALL 101 37
04 Jun 14:56 20 Sep, 2024 40.00 CALL 81 37
04 Jun 14:56 20 Sep, 2024 40.00 CALL 205 37
04 Jun 14:58 18 Oct, 2024 40.00 CALL 116 98
04 Jun 16:07 20 Sep, 2024 40.00 CALL 88 37
12 Jun 17:35 17 Jan, 2025 47.50 CALL 501 127
12 Jun 17:35 17 Jan, 2025 47.50 CALL 99 127
12 Jun 19:21 20 Sep, 2024 45.00 PUT 48 21
14 Jun 17:00 19 Jul, 2024 45.00 CALL 2460 1870

About Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; WAYLIVRA, a treatment for familial chylomicronemia syndrome and familial partial lipodystrophy.